Chengshan Niu

Title: Chengshan Niu: Innovator in Pharmaceutical Compounds

Introduction

Chengshan Niu is a prominent inventor based in Zhengzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurodegenerative diseases and cancer. With a total of 2 patents, Niu's work is paving the way for innovative treatments.

Latest Patents

Niu's latest patents include a [1,3]thiazin-2-amine compound, which is directed towards applications and pharmaceutical compositions. This invention focuses on BACE inhibitors, showcasing a compound that exhibits a strong inhibitory effect on BACE. It holds potential for preparing medications aimed at treating neurodegenerative diseases, such as Alzheimer's disease. Another notable patent involves bis-quinazoline derivatives as inhibitors for epidermal growth factor receptor (EGFR) tyrosine kinase. This invention discloses novel methods for treating diseases mediated by tyrosine kinase, particularly various cancers, using these innovative compounds.

Career Highlights

Throughout his career, Chengshan Niu has worked with notable companies, including Tetranov International Inc. and Tetranov Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Niu has collaborated with esteemed colleagues, including Yusheng Wu and Jingya Li. These partnerships have further enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Chengshan Niu's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a dedication to developing effective treatments for serious health conditions.